clinical trials

Allakos sustains its gains on strength of GI readout
Allakos sustains its gains on strength of GI readout
BioCentury
Alllakos
clinical trials
eosinophilic gastritis
AK002
Flag link:
Astellas pushes non-hormonal menopause drug into phase 3
Astellas pushes non-hormonal menopause drug into phase 3
Pharmaforum
Astellas
menopause
clinical trials
fezolinetant
Flag link:
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
Endpoints
Lynparza
AstraZeenca
Merck
prostate cancer
clinical trials
Flag link:
Rhythm’s genetic obesity drug hits primary endpoint in phase 3
Rhythm’s genetic obesity drug hits primary endpoint in phase 3
Fierce Biotech
Rhythm Pharmaceuticals
genetic obesity
clinical trials
setmelanotide
Flag link:
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
Stat
clinical trials
pay-to-play
Flag link:
Sanofi ends partnership with Lexicon after trial failure
Sanofi ends partnership with Lexicon after trial failure
In-Pharma Technologist
Sanofi
Lexicon Pharmaceuticals
clinical trials
Zynquista
diabetes
Flag link:
Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study
Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study
Endpoints
Eli Lilly
Emgality
clinical trials
migraines
chronic migraine
episodic migraine
Flag link:
SillaJen, Transgene fall with latest oncolytic virus setback
SillaJen, Transgene fall with latest oncolytic virus setback
BioCentury
Transgene
SillaJen
clinical trials
Pexa-Vec
oncolytic viruses
Flag link:
Medicines Co. awaits its date with destiny
Medicines Co. awaits its date with destiny
Biopharma Dive
The Medicines Company
clinical trials
inclisiran
Flag link:
Novartis' Kisqali sharpens survival edge with second ph3 win
Novartis' Kisqali sharpens survival edge with second ph3 win
Fierce Pharma
Novartis
Kisqali
breast cancer
clinical trials
Flag link:
Amgen results beat estimates, lung cancer trial planned
Amgen results beat estimates, lung cancer trial planned
Yahoo/Reuters
Amgen
earnings
clinical trials
lung cancer
AMG510
Flag link:
Lilly cancer push boosted by survival benefit to key drug
Lilly cancer push boosted by survival benefit to key drug
Biopharma Dive
Eli Lilly
Verzenio
metastatic breast cancer
clinical trials
Flag link:
The patent play: Biogen gets a PhIII boost for its bit-better take on the blockbuster MS franchise drug Tecfidera
The patent play: Biogen gets a PhIII boost for its bit-better take on the blockbuster MS franchise drug Tecfidera
Endpoints
Biogen
Alkermes
MS
multiple sclerosis
Vumerity
clinical trials
Flag link:
Merck Data Are Another Step for Immunotherapy in Breast Cancer
Merck Data Are Another Step for Immunotherapy in Breast Cancer
Xconomy
Merck
Keytruda
clinical trials
triple negative breast cancer
Flag link:
Novartis heart drug fails trial, curbing growth prospects
Novartis heart drug fails trial, curbing growth prospects
Yahoo/Reuters
Novartis
heart failure
Entresto
clinical trials
Flag link:
Cidara posts data from head-to-head trial against Merck antifungal
Cidara posts data from head-to-head trial against Merck antifungal
Fierce Biotech
Cidara
antifungals
rezafungin
clinical trials
Merck
Cancidas
Candida
Flag link:
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
biotech
earnings
Immunic
Alkermes
Conatus
Aevi Genomic
Tricida
Curis
Ultragenyx
Leap Therapeutics
Cidara Therapeutics
Akcea
Spark Therapeutics
Eli Lilly
AnaptysBio
clinical trials
Flag link:
Editas, Allergan launch first in vivo study of CRISPR-based medicine
Editas, Allergan launch first in vivo study of CRISPR-based medicine
BioPharma Dive
Editas Medicine
Allergan
clinical trials
CRISPR
EDIT-101
Flag link:
Marinus leaves the way clear for Sage
Marinus leaves the way clear for Sage
EP Vantage
Marinus Pharma
SAGE Therapeutics
ganaxolone
clinical trials
postpartum depression
Flag link:
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Pharmaceutical Business Review
Novartis
Sandoz
biosimilars
clinical trials
denosumab
osteoporosis
Prolia
Xgeva
Flag link:

Pages